To address this, our study aims to leverage the TriNetX database to compare the outcomes of patients treated with GLP-1 RA in addition to SGLT2i vs. those treated with SGLT2i alone, with a specific focus on hard endpoints such as mortality and HF hospitalizations. Here, GLP1R is linked to hydrops fetalis.